<!-- [![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.231352.svg)](https://doi.org/10.5281/zenodo.231352) -->

### Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Christian Schmidl<sup>\*</sup>, Gregory I Vladimer<sup>\*</sup>, André F Rendeiro<sup>\*</sup>, Susanne Schnabl<sup>\*</sup>, Tea Pemovska, Thomas Krausgruber, Mohammad Araghi, Nikolaus Krall, Berend Snijder, Rainer Hubmann, Anna Ringler, Dita Demirtas, Oscar Lopez de la Fuente, Martin Hilgarth, Cathrin Skrabs, Edit Porpaczy, Michaela Gruber, Gregor Hörmann, Stefan Kubicek, Philipp B Staber, Medhat Shehata<sup>\*\*</sup>, Giulio Superti-Furga<sup>\*\*</sup>, Ulrich Jäger<sup>\*\*</sup>, Christoph Bock<sup>\*\*</sup>. Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL. Nature Chemical Biology (2019) [10.1038/s41589-018-0205-2](https://doi.org/10.1038/s41589-018-0205-2).

<sup>\*</sup>Shared first authors
<sup>\*\*</sup>Shared last authors

**Paper supplementary website**: [cll-synergies.computational-epigenetics.org](http://cll-synergies.computational-epigenetics.org)

**GEO accession**: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE100672
